Zenas BioPharma, Inc. Contracts & Agreements
29 Contracts & Agreements
- Business Finance (3 contracts)
- Business Operations (1)
- Human Resources (19)
- Intellectual Property (6)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on September 6, 2024)
- Transition and Separation Agreement between the Registrant and Tanya Fischer, dated August 29, 2024 (Filed With SEC on September 6, 2024)
- Amended and Restated Employment Agreement between the Registrant and Orlando Oliveira, dated September 4, 2024 (Filed With SEC on September 6, 2024)
- Amended and Restated Employment Agreement between the Registrant and Jennifer Fox, dated September 4, 2024 (Filed With SEC on September 6, 2024)
- Amended and Restated Employment Agreement between the Registrant and Joseph Farmer, dated September 4, 2024 (Filed With SEC on September 6, 2024)
- Amended and Restated Employment Agreement between the Registrant and Leon O. Moulder, Jr., dated September 4, 2024 (Filed With SEC on September 6, 2024)
- Zenas BioPharma, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 6, 2024)
- Form of Zenas BioPharma, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on September 6, 2024)
- Form of Global Non-Qualified Stock Option Agreement under the Zenas BioPharma, Inc. 2024 Equity Incentive Plan (Filed With SEC on September 6, 2024)
- Form of U.S. Non-Qualified Stock Option Agreement under the Zenas BioPharma, Inc. 2024 Equity Incentive Plan (Filed With SEC on September 6, 2024)
- Form of Zenas BioPharma, Inc. 2024 Equity Incentive Plan (Filed With SEC on September 6, 2024)
- Zenas BioPharma, Inc. Short-Term Incentive Plan (Filed With SEC on September 6, 2024)
- Fourth Amended and Restated Shareholders Agreement, among the Registrant and certain of its stockholders, dated May 3, 2024 (Filed With SEC on September 6, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 6, 2024)
- Transition and Separation Agreement between the Registrant and Hua Mu, dated June 29, 2023 (Filed With SEC on August 22, 2024)
- License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated September 23, 2020 (Filed With SEC on August 22, 2024)
- Employment Agreement between the Registrant and Tanya Fischer, dated September 22, 2023 (Filed With SEC on August 22, 2024)
- Form of Incentive Stock Option Agreement under the Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Form of Non-Qualified Stock Option Agreement (Employees) under the Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) under the Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Form of Restricted Share Agreement under the Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Amendment to Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Amendment to Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Zenas BioPharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- License Agreement by and between the Registrant and Bristol-Myers Squibb Company, dated as of August 30, 2023 (Filed With SEC on August 22, 2024)
- Second Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- First Amendment to License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- First Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated June 24, 2024 (Filed With SEC on August 22, 2024)
